These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5121343)

  • 1. The BaSon test: a rapid bedside test for control of heparin therapy.
    Baden JP; Sonnenfield M; Ferlic RM; Sellers RD
    Surg Forum; 1971; 22():172-4. PubMed ID: 5121343
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin time dilution test: a simple method for the control of heparin therapy.
    Pizzuto J; García-Méndez S; de-la-Paz Reyna M; Morales MR; Avilés A; Zavala B; Gaos C
    Thromb Haemost; 1979 Dec; 42(4):1276-85. PubMed ID: 542933
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardized methods for heparin therapy.
    Soloway HB
    N Engl J Med; 1973 Aug; 289(8):429-30. PubMed ID: 4719832
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory control of heparin therapy with the activated partial thromboplastin time test.
    Degnan TJ; Karasik S; Lenahan J
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):390-6. PubMed ID: 4979988
    [No Abstract]   [Full Text] [Related]  

  • 5. Activated partial thromboplastin time test in heparin therapy. A study.
    Simmons A; Cross DE
    Mo Med; 1969 Jun; 66(6):430-3. PubMed ID: 5771362
    [No Abstract]   [Full Text] [Related]  

  • 6. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 10. The laboratory control of heparin therapy.
    Estes JW
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):58-65. PubMed ID: 808391
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):634-7. PubMed ID: 7314057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring the effect of heparin bolus during percutaneous coronary angioplasty (PTCA): assessment of three bedside coagulation monitors.
    Hézard N; Metz D; Potron G; Nazeyrollas P; Maes D; Droulle C; Mulpas MC; Elaerts J; Nguyen P
    Thromb Haemost; 1998 Nov; 80(5):865-6. PubMed ID: 9843190
    [No Abstract]   [Full Text] [Related]  

  • 14. A simple technique for the measurement of plasma heparin concentration during anticoagulant therapy.
    Marder VJ
    Thromb Diath Haemorrh; 1970 Oct; 24(1):230-9. PubMed ID: 5483963
    [No Abstract]   [Full Text] [Related]  

  • 15. The activated coagulation time test as a control for heparin therapy.
    Cho P; Bonilla-Linero F; Yim E
    Hawaii Med J; 1971; 30(6):474-7. PubMed ID: 5156964
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of various laboratory tests in the control of anticoagulant therapy].
    Molinas FC; Sanchez Avalos JC
    Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645
    [No Abstract]   [Full Text] [Related]  

  • 17. A capillary test for the control of heparin therapy.
    Jiménez F; Atmetlla F
    J Lab Clin Med; 1976 May; 87(5):893-7. PubMed ID: 1270895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of heparin by kaolin.
    Barrowcliffe TW; Sims GE
    Thromb Haemost; 1976 Nov; 36(2):483-4. PubMed ID: 1036847
    [No Abstract]   [Full Text] [Related]  

  • 19. [Difference in examination of coagulation function in heparin anticoagulant therapy between point of care tests and automatic coagulation analyzer].
    Li J; Cong YL; Tu GH; Yang L; Zhu BB; Jin L
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1269-71. PubMed ID: 17686264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring heparin therapy.
    Stevens DJ; Latorraca R
    Wis Med J; 1977 Mar; 76(3):33-6. PubMed ID: 842040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.